Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03163199 · ClinicalTrials.gov registry record
TRanslesIonal Assessment of Gradients During Endovascular Therapy
A clinical trial, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- 22
- Enrollment target
NCT03163199 is a clinical trial that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 22 participants.
The verdict
NCT03163199 has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
Primary objective: To document change in translesional pressure gradients (TLPGs) and ratios (fractional flow reserve) using the NAVVUS RXi catheter following endovascular treatment for symptomatic lower extremity peripheral arterial disease. Secondary objectives: * Evaluation of correlation of the ABI and TBI and TLPGs at baseline and following endovascular therapy * Evaluation of the correlation between the change in WIQ, TCOMs, wound size and change in TLPGS * Evaluation of correlation between lesion severity by QVA (MLD, % diameter stenosis) and TLPGs * Evaluation of baseline MLA, MLD, plaque burden by intravascular ultrasound (optional) and TLPGs
Interventions
- DEVICE Translesional Hemodynamic Measurement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2017-04-12 |
| Est. Completion | 2022-02-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03163199
The ClinicalTrials.gov registry entry for NCT03163199 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Translesional Hemodynamic Measurement is the first listed.
NCT03163199 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03163199 about?
NCT03163199 is a clinical study titled "TRanslesIonal Assessment of Gradients During Endovascular Therapy". Primary objective: To document change in translesional pressure gradients (TLPGs) and ratios (fractional flow reserve) using the NAVVUS RXi catheter following endovascular treatment for symptomatic lower extremity peripheral arterial disease. Secondary objectives: * Evaluation of correlation of th...
What is the current status of trial NCT03163199?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2017-04-12. Estimated completion is 2022-02-16.
What interventions are being tested in trial NCT03163199?
The interventions under investigation include: Translesional Hemodynamic Measurement (DEVICE).
Who is sponsoring clinical trial NCT03163199?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.